MACULAR EDEMA SECONDARY TO INFLAMMATION
Clinical trials for MACULAR EDEMA SECONDARY TO INFLAMMATION explained in plain language.
Never miss a new study
Get alerted when new MACULAR EDEMA SECONDARY TO INFLAMMATION trials appear
Sign up with your email to follow new studies for MACULAR EDEMA SECONDARY TO INFLAMMATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New eye drug aims to restore sight in inflammatory swelling
Disease control Recruiting nowThis study tests an experimental drug, tabirafusp alfa (KSI-101), given as an eye injection to treat macular edema (swelling in the back of the eye) caused by inflammation. About 600 adults with vision loss from this condition will receive either the drug or a sham injection. The…
Matched conditions: MACULAR EDEMA SECONDARY TO INFLAMMATION
Phase: PHASE3 • Sponsor: Kodiak Sciences Inc • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New eye drug aims to restore vision in inflammatory swelling
Disease control Recruiting nowThis study tests an experimental eye injection called tabirafusp alfa (KSI-101) for people with macular edema (swelling in the back of the eye) caused by inflammation. About 150 adults with active or past eye inflammation and mild to moderate vision loss will receive either the d…
Matched conditions: MACULAR EDEMA SECONDARY TO INFLAMMATION
Phase: PHASE3 • Sponsor: Kodiak Sciences Inc • Aim: Disease control
Last updated May 18, 2026 12:09 UTC